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1. Introduction  
At the world level, head and neck cancer is the sixth most common cancer (Fedele 2009). 
Oral squamous cell carcinoma (OSCC) accounts for about 40% of head and neck and 90-95% 
of oral malignancies (Neville et al. 1995; Pektas et al. 2006). OSCC is proceeded by visible 
changes in the oral mucosa, such as: white plaque, redness, ulcer or exophytic lesion, with 
no other signs/symptoms. (Delavarian et al. 2010). If OSCC is diagnosed and treated in this 
stage, it will be curable and inexpensive to treat with excellent treatment outcomes and 
survival (Rosenberg and Cretin 1989). 
Five-year survival is about 76% to 80% if diagnosis is performed in stage 1 and 2. Late 
diagnosis in stage 3 and 4 can decrease this value to 41% and 9% respectively (Mashberg 
and Feldman 1988; Neville et al. 1995; Maraki, Becker, and Boecking 2004; Pektas et al. 2006). 
At this time, metastasis to regional lymph nodes has occurred and cancer cannot be treated 
without undesirable complications and morbidity (such as mucosities, xerostomia, surgical 
defect, etc.…). Unfortunately majority of cases are diagnosed at stage 3 and 4 with more 
than 50% of them exhibiting metastatic lymphadenopathy (Eisenbud and Sciubba 1978). 
Despite advances in diagnostic procedures in medical practice, mortality of OSCC has 
remained unchanged in the past 40 years and and a significant diagnostic delay (up to 8 
months)has persisted over time. (Abdo et al. 2007; Peacock, Pogrel, and Schmidt 2008) For 
example, the mortality rate for oral cancer is similar to that of colon cancer even though it is 
much easier to screen and detect oral cancers than it is for colon cancer. The most important 
factor in patient survival and prognosis is early diagnosis. Studies have shown that most 
OSCC could have been detected 3 to 7 month earlier by a trained dentist (Bruun 1976), but 
as mentioned, 50% of patients have regional or distant metastasis at the time of diagnosis 
(Acha 2005; Fedele 2009). There are some reasons for this delay (Wood and Goaz 1997;Abdo 
et al. 2007; Peacock, Pogrel, and Schmidt 2008;): 
1. Lack of public awareness about signs, symptoms and risk factors of oral cancer. 
2. Absence of routine oral examination in at least 50% of public. 
3. Absence of symptoms in early stages of oral cancer. 
4. Development of cancer in parts of oral cavity which normally scape inspection by the 
patients and/or physician (e.g. floor of the mouth). 
5. Similarity of lesions to benign ones (e.g.; candidiasis, recurrent aphthous stomatitis, etc.). 
6. Absences of prevention and early detection by heath care providers (e.g. lack of 
knowledge and ability to recognize oral cancer in early stages and absence of generally 
accepted screening tests which can be easily performed by general dentists). 
www.intechopen.com
 
Oral Cancer 
 
190 
OSCC very often arises from an oral premalignant lesion (OPL). OPL is defined as a benign, 
morphologically altered tissue that has a greater than normal risk of malignant 
transformation((Neville et al. 1995 ). Erythroplakia, leukoplakia, oral lichen planus and oral 
submucous fibrosis are examples of OPL. Erythroplakia either isolated or concomitant with 
leukoplakia may show severe dysplasia or carcinoma In Situ. Indeed 90% of erthroplakia 
lesions are histologically diagnosed as carcinoma In Situ or cancer (Mashberg and Feldman 
1988; Mills and Carter 2004; Maraki, Becker, and Boecking 2004; Kujan et al. 2005). 
Leukoplakia is the most common OPL in the oral cavity with a 4-40% chance for malignant 
changes (Waldron and Shafer 1975; Sciubba 1999; Maraki, Becker, and Boecking 2004). A 
new cohort showed that 17.9% of leukoplakia lesions developed into oral cancer with a 
mean duration of 5.2 years. (Liu et al. 2010). Oral lichen planus may become cancerous in 0.4 
to 2.5% of cases (Sciubba 1999;Maraki, Becker, and Boecking 2004). A new retrospective 
study in Spain revealed 0.9% chance of malignancy in oral lichen planus with the tongue as 
the most common location (Bermejo-Fenoll et al. 2009).  
Sometimes oral cancer develops de novo- from a normal mucosa- and is not preceded by an 
OPL, but usually a small part of an OPL may undergo dysplasia or malignant changes. 
Early removal of this part can prevent emergence of malignant lesions. But the question is- 
how can we find early malignant changes in an apparently benign lesion? To answer this 
question we must be familiar with adjunctive diagnostic aids which if employed properly, 
can enhance diagnosis and improve treatment outcomes. In the next section we introduce 
the diagnostic aids in oral Cancer screening or diagnosis. 
2. Diagnostic aids in screening of oral cancer  
Diagnostic aids can help the physician to decide whether the suspicious lesion needs biopsy 
or removal for cancer detection. Sometimes malignant changes occur without any clinical 
evidence of malignancy. In this situation even an expert eye may overlook malignant 
changes. Diagnostic aids can reveal these occult changes. In other word, diagnostic aids can 
be used as screening or as adjunctive tools. The decision whether to screen for oral cancer or 
not depends on many factors. Table1 shows the criteria for implementation of a screening 
program. (Lingen et al. 2008) when screening is indicated for oral cancer in a certain 
population, a suitable test should be employed. Table2 illustrates the characteristics of a 
good screening test. (Lingen et al. 2008)  
 
The disease must be an important health problem 
An accepted treatment must be available for patients with recognized disease 
Facilities for diagnosis and treatment must be available
There must be a recognizable latent or early symptomatic stage
A suitable test must be available
The test should be acceptable to the population
The natural history of the condition should be adequately understood
There should be an agreed policy on whom to treat as patients
The screening program should be cost-effective
The screening process should be a continuing process and not a ‘once and for all’ 
project 
Table 1. Criteria for the implementation of a screening program (Lingen et al. 2008) 
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There are different screening tests for oral cancer with variable indications, limitations and 
implications. Yet the gold standard for cancer diagnosis is surgical biopsy and 
histopathologic examination. But not every suspicious lesion should be surgically biopsied. 
There is a spectrum ranging from clinical examination to surgical biopsy. Diagnostic tests 
are located in the middle of this spectrum and have their own indications. Here we discuss 
diagnostic procedures, which can be employed in early detection of oral cancer.  
 
A screening test should: 
 
Be simple, safe and acceptable to the public 
 
Detect disease early in its natural history 
 
Preferentially detect those lesions which are likely to progress 
 
Detect lesions which are treatable or where an intervention will prevent progression 
 
Have a high positive predictive value and low false negatives (high sensitivity)     
Table 2. Characteristics of a good screening test (Lingen et al. 2008) 
Screening test must be evaluated with respect to their diagnostic value. This value includes 
sensitivity (SN), specificity (SP), positive predictive value (PPV) and negative predictive 
value (NPV). If calculating of these values is considered the results must be compared to the 
gold standard. The gold standard of oral cancer diagnosis is yet scalpel biopsy (surgical 
biopsy). The gold standard is used to classify subjects as to their true state of disease. Table 3 
shows the SN, SP, PPV and NPV and the way to calculate them. 
a
SN
a c
d
SP
d b
a
PPV
a b
d
NPV
d c
 
 
 
 
 
 
Total 
Gold Standard
 
D
ia
gn
os
ti
c 
te
st
 
Disease absentDisease present
a+d 
d 
False positive 
a 
True positive 
+ 
c+b 
b 
True negative 
c 
False negative 
 - 
a+b+c+d b + da + cTotal
Table 3. Standard 2X2 table for the calculation of sensitivity(SN), specificity(SP), positive 
predictive value(PPV) and negative predictive value(NPV) 
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2.1 Clinical examination 
Diagnosis of oral cancer begins with a complete history taking followed by a thorough 
clinical examination. Oral cavity is the most accessible site of alimentary track for clinical 
examination. (Chiodo, Eigner, and Rosenstein 1986)Precise inspection of all parts of oral 
mucosa using an incandescent light can reveal abnormal changes. The physician must 
examine the whole oral cavity accurately. Posterior portions and floor of the mouth must be 
surveyed meticulously. Even self-examination of oral cavity can be performed by the 
individuals for early detection of oral cancer (Elango et al. 2011). Any symptom or sign must 
be assessed exactly. The teeth must be examined for any evidence of mobility or tilting. 
Sometimes radiographic examination is necessary to complete the clinical examination. The 
clinician must palpate any lesion to find induration or firmness. Apparently normal mucosa 
must be palpated to reveal any mass or abnormal change (e.g. roughness, altered texture…). 
Cervical lymph nodes must be palpated to find metastatic lymphadenopathy in occult 
oropharynx malignancy 
At the time of evaluating an OPL, any evidence of roughness, ulceration, redness and 
induration must be further examined by histopathologic examination. Diagnostic value of 
clinical examination has been reported in literature. (Sankaranarayanan et al. 2005; Downer 
et al. 1995; Nagao et al. 2000; Jullien et al. 1995; Downer et al. 2004; Mignogna and Fedele 
2005). A Meta analysis on different studies of oral cancer screening showed an overall 
sensitivity of 0.857. (95% CI 0.73, 0.92) and specificity of 0.97(95%. CI 0.93, 0.98), Indicating a 
satisfactory test performance for oral examination (Downer et al. 2004). This study also 
suggested that trained auxiliaries are able to screen with a degree of accuracy similar to 
dental practitioner.  
Mortality of oral cancer can be decreased by clinical examination. One study reported a 32% 
reduction in mortality of OSCC in high risk individuals, suggesting that about 40000 deaths 
can be prevented by oral examination worldwide (Mignogna and Fedele 2005; 
Sankaranarayanan et al. 2005). Even self examination can improve early detection of oral 
cancer, although compliance to seek treatment is still low (32%).(Elango et al. 2011; 
Warnakulasuriya et al. 1984) . False positive referrals for definite diagnosis can result in 
anxiety which can be decreased by public education for the individuals who receive oral 
examination. (Patton 2003) 
To increase cost effectiveness of oral cancer screening programs, it is better to perform 
targeted clinical examinations of high-risk subjects (opportunistic screen) than mass 
screening (Speight et al. 2006; Patton 2003). A Cochrane systematic review found that there 
is no evidence to recommend inclusion or exclusion of screening for oral cancer using a 
visual examination unless randomized controlled trials provide the most reliable 
information for decision in clinical practice (Kujan et al. 2005). 
Despite benefits of clinical examination, it has been demonstrated that between 4.5 and 
15.3% of OPL and early stage oral cancers can not be adequately identified by visual 
inspection alone and may be overlooked even by highly trained professionals, potentially 
increasing the false negative rate (Moles, Downer, and Speight 2003). Because of this innate 
pitfall of visual inspection, other diagnostic aids can be employed to improve early detection 
of oral cancer. 
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2.2 Cytopathologic studies  
2.2.1 Oral exfoliative cytology  
Cythopathology is the microscopic study of cell samples collected from mucosal surfaces 
obtained by exfoliative cytology (via smears, scraping or lavage) or by fine needle aspiration 
(Sarah Freygang et al. 2011). Cytology has been applied to diagnose human diseases, since 
Papanicolaou and Traut validated it for diagnosis of cervical cancer (Papanicolaou GN 
1941). Since then cytology of the oral cavity began to be used as a cytopathologic diagnostic 
technique. In early studies on this technique no satisfactory results were obtained, mainly 
due to its limitations and improper application. In this technique a collecting devise (swab, 
spatula and brush) is placed and rotated against the mucosal surface and the cells are 
collected. 
The next step is to prepare a smear by spreading the cells onto a glass slide. After fixation 
and papanicolaou staining the slide is examined by pathologist. Interpretation of the results 
must be performed by an expert pathologist familiar with cytopathology. Sometimes cells 
are collected by a cytobrush. Diagnostic values of exfoliative cytology have a wide range 
due to kind of sampling instrument. A positive result is defined as definitive cellular 
evidence of epithelial dysplasia or carcinoma and atypical result is defined as abnormal 
epithelial changes of uncertain diagnostic significance (Maraki, Becker, and Boecking 2004). 
Studies from 1950 to 1970s reported high false negative results for exfoliative cytology 
(Folsom et al. 1972; Shklar, Cataldo, and Meyer 1970; Rovin 1967). For example Folsom et all 
reported 37% false negative result in 148 oral lesions (Folsom et al. 1972). 
Recent studies have reported better results (Navone et al. 2004) due to combining molecular 
analysis with exfoliative cytology which will be discussed in a separate section. Some 
researchers have analyzed the reliability of oral cytology and it’s cytometric analysis in the 
early detection of oral cancer. The SN 98.2%, SP100%, PPV of 100% and NPV of 99% have 
been reported (Remmerbach et al. 2003). Mehrotra et al Reviewed 22 articles and found SN 
and SP of oral exfoliation cytology to be 76.8% - 100% and 88.9% - 100% respectively 
(Mehrotra et al. 2009). 
2.2.2 Brush biopsy  
Oral CD-x brush is a kind of specialized oral brush, which can penetrate the thickness of the 
mucosa and collect representative sample of the lesion. (Acha 2005)Basal and parabasal 
cells- which are the precursor of malignant changes- are collected by this specially designed 
brush. “Brush biopsy” employs oral CD-x brush, which is then analyzed by computer. Some 
studies have used oral CD-x brush, but have analyzed the result by visual histopathology 
examination and not by computer (Mehrotra et al. 2006;Delavarian et al 2010). 
The diagnostic value of brush biopsy has been reported in several studies. SN from 71 to 100 
percent, SP varied from 27 to 94 percent, PPVs ranged from 38 to 88 percent and NPVs from 
60 to 100 percent have been reported. According to a systematic review by Patton et all, oral 
CD-x cytological test has advantages in detecting dysplastic changes in high risk mucosal 
lesions but in low risk populations or clinical innocuous lesions its application remains in 
doubt. This technique can not be performed in place of surgical biopsy.(Patton, Epstein, and 
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Kerr 2008) It seems that OralCDx technique overestimates dysplastic lesions and has a low 
PPV(Bhoopathi, Kabani, and Mascarenhas 2009) 
2.2.3 Liquid based cytology (LBC)  
Since 1990, liquid-based cytology (LBC) has been designed to improve slide quality and 
quantity of conventional cytology (Davey et al. 2006). LBC is an improvement in cytology 
technique that can compensate many disadvantages of conventional exfoliate cytology. 
Instead of a unique smear, a suspension of cells is obtained and several slides could be 
prepared. In LBC the sample collector with the sample is immersed in a tube containing 
preservative fluid, which fixes the cells immediately and can be a useful source of cells for 
upcoming researches. The fluid is placed on a centrifugal force and the cells make a thin 
high cellular confined zone on the glass slide, which can be assessed easily by the 
pathologist. Many artifacts of conventional cytology do not occur in LBC technique. By 
employing this technique unsatisfactory slides and false negative results have been reduced 
and the diagnostic value of cytology has improved. Up to now, only few studies in oral 
cavity –based on LBC technique- have been published in English literature. In Hayama 
study; 44 different oral lesions were examined by both conventional and liquid based 
(Autocyte Inc) cytological examination using a cytobrush –not specified for oral mucosa. It 
was concluded that the two techniques led to the same diagnosis and the same 
papanicolaou class was assigned in all adequate cases. Three  conventional smears were 
hypocellular, hence making the cytological diagnosis impossible. The LBC preparations 
showed a satisfactory higher improvement in slide quality (thinness, even cell distribution, 
absence of overlapping and bleeding) (Hayama et al. 2005).  
In Navone study 2006, results of conventional exfoliative cytology and LBC (by using 
dermatologic curette) were compared with scalpel biopsy. Both sensitivity and specificity 
were higher in LBC group than in conventional cytology. The false negative and positive 
results were 7/89 and 2/89 in conventional smear group and  4/384 and 3/384 in LBC 
group. Upon these results, it can be concluded that LBC gives better results and enhances 
SN and SP (Navone et al. 2007). Recently Navone reported a 95.1% SN and 99% SP for LBC 
technique. (Navone 2009)  
2.2.4 A modified liquid-based cytology using OralCDx® Brush 
Although the diagnostic values of brush biopsy or LBC technique have been published 
previously there are some pitfalls: First, in many brush biopsy studies not all of samples 
with different brush results underwent scalpel biopsy so the reported values for sensitivity, 
specificity, etc., could be questionable. Second, in the case of performing both brush and 
biopsy, there are few, if ever, studies which both techniques are done simultaneously and 
exactly from the same area. Third, all of LBC studies in oral cavity are performed using 
cervical or dermatological tools for sample collection and never a specialized oral tool 
(e.g.CDx brush) has been employed (Hayama et al. 2005; Navone et al. 2007). Because of non 
rigid nature of cervical brushes, inadequate results  are expected. This leads to false negative 
results and significant diagnostic delay (Potter, Summerlin, and Campbell 2003). 
So, we planned a study to use LBC technique employing a specialized oral brush 
(OralCDx® Brush), simultaneously and exactly from the same area to determine the 
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diagnostic value (sensitivity, specificity, positive and negative predictive values and positive 
and negative likelihood ratios) of modified LBC technique in detection of dysplasia 
/malignancy in oral potentially malignant and cancerous lesions and to evaluate diagnostic 
agreement between this technique and scalpel biopsy. (Delavarian et al. 2010) 
Since only a few laboratories evaluate the OralCDx® results by computer-assisted analysis, 
we examined microscopic slides visually. First, we designed a pilot study on 3 normal 
mucosa and 7 epithelial lesions to qualify slide properties, using standard protocol of 
OralCDx® kits. After manipulation of standard protocol neither the quality nor the quantity 
of slides were suitable for cytopathologic diagnosis, so we applied an LBC technique and 
modified the conventional protocol in this way:  
First, instead of spreading the brush onto a glass slide, the brush was placed in the supplied 
glass tube, containing formalin (10%), and sent to the cytopathology laboratory. There the 
brush and the formalin, containing cells dispersed from brush were placed in a vortex for 5 
minutes in 4000 RPM. This centrifugal force helped to sediment the cells and taken them off 
from the brush hairs. Then 100 λ (mm3) of this sediment was placed onto the cup of 
Cytospine (Shandon UK) centrifuge in 1000RPM(similar to power recommended in this 
vortex for vaginal samples). Two to 4 samples were obtained from each cellular sediment. 
The more the sediment was rich in cellular material or blood component, the more glass 
slides were prepared. 
The study group consisted of 25 patients with 26 lesions which had been visited from Oct 
2005 to Jan 2007, at Oral Medicine Department of Mashhad Faculty of Dentistry and 
Otorhinolaryngology Departments of QAEM, IMAM REZA and OMID hospitals, Mashhad, 
Iran. (Table 4)The study protocol was approved by the committee on ethics of Mashhad 
University of the Medical Sciences (MUMS) on the basis of the Helsinki consent 
2005.Patients were informed with regard to the research objectives, methods, possible 
benefits and potential risks and a written consent was obtained from all participants. 
Inclusion criterion was: lesions clinically diagnosed as oral potentially malignant 
(leukoplakia, OLP) or malignant lesions (OSCC and verrucous carcinoma) and requiring an 
incisional (scalpel) biopsy for definite diagnosis. Exclusion criteria were: A) History of any 
treatment for the lesion (drug, radiation and chemotherapy) and B) A systemic 
contraindication for scalpel biopsy. 
The most appropriate site of biopsy was determined upon the most probable site of 
dysplasia/malignancy (e.g. presence of firmness and indurations and roughness or red 
surface or high risk areas for dysplasia/malignancy (e.g. Ventral tongue and floor of the 
mouth) or the most surgically accessible site. 
Demographic data were recorded. After determination of the site of biopsy, under local 
anesthesia, needed for scalpel biopsy, the Oral CDx brush was placed in the selected area 
and turned 5 to 10 times until appearing pinpoint bleeding-upon to manufacturer’s 
recommendation. The brush was sent to cytopathology laboratory immersing in supplied 10 
%formalin glass tube. The  scalpel biopsy was also done immediately in site of pinpoint 
bleeding. 
In cytopathology laboratory, the slides were prepared by Modified Liquid Based 
Techniques. By using cytospine vortex the cells were compacted in a 20mm2 area ,then they 
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were fixed in 96° alcohol for 20 minutes and papanicolaou staining was done. They were 
examined by a pathologist informed about clinical diagnosis, but blind to the 
histopathological results; using Leica BME (Leica Buffalo state, US) microscopes in 100X and 
400X magnifications. 
The cytopathological findings were categorized as three groups: 1) Positive: dysplastic 
epithelial changes. 2) Negative: absence of any evidence suggesting dysplasia.3) Inadequate 
sampling: means two entities:A) Inadequate depth of sampling –absence of basal and 
parabasal cell layers in slide.B) Inadequate quantity of cells-hypocellularity.  
The histopathologic preparations were observed by the same pathologist blind to 
cytopathological study and informed about clinical diagnosis. The Pindborg criteria 
(Warnakulasuriya et al. 2008) for detecting dysplasia and malignancy were used and the 
histopathologic diagnosis was made .The presence of dysplasia/malignancy in 
histopathology(P.D.M.H) was classified as normal(no dysplasia/malignancy),mild, 
moderate and severe dysplasia (level 1 to 3),carcinoma In Situ(level 4) and carcinoma(level 
5)(table 4). 
Quantitative variables were analyzed by T test as X ±SD and for qualitative variables χ2 
and Exact Fisher tests were done using SPSS11.5 software. SN, SP, PPV and NPV were 
calculated for modified technique and clinical examination. Positive likelihood ratio (LR+) 
and negative likelihood ratio (LR-) were calculated for modified technique. Kappa value 
was calculated to determine diagnostic agreement between the modified technique and 
scalpel biopsy, the gold standard.  
Thirteen male and 12 female contributed to this study (Table 4).In one female patient (Table 
4 -pt (patient) No 25) two sites with two different clinical diagnoses (one proved to be 
severely dysplastic and one OSCC in histopathologic assessment) were biopsied (Fig 1). The 
mean age of patients was 54.00±17.38 (12 females; 54.23±19.77and 13 males; 53.77±15.43 
years).T test revealed senile contingency in two groups. Six lesions were clinically diagnosed 
as OLP, six as leukoplakia, 13 as OSCCs and one as verrucous carcinoma (Table 4).  
The Modified LBC results showed 10 negative and 16 positive results  ,without any 
inadequate results, hence all the specimens were included basal and parabasal layers and 
enough quantity. Histopathologic results were as follow : ( Table 4) 7 lesions diagnosed as 
OLP, 5 as leukoplakia, 11 as OSCC and one as verrucous carcinoma, two lesions(pt Nos 9 
and 23) , were diagnosed as Granular Cell Tumors (GCT) of tongue.  
Clinical diagnosis was in agreement in 88.4% (23/26) with histopathological findings. One 
lichenoid reaction clinically diagnosed as leukoplakia and two granular cell tumors 
clinically diagnosed as OSCCs. In 92.3 %( 24/26, p<0.001) results of modified LBC were in 
agreement with presence of malignancy/dysplasia in histopathology. The two false negative 
results were outcomes of histopathologically focal dysplasia (one mild and one moderate 
dysplasia).  
Kappa value (an index of diagnostic agreement) was calculated 0.806 for modified LBC and 
scalpel biopsy. In our study, SN, SP, PPV and NPV of modified LBC technique were 
calculated as follows: 88.8%, 100%, 100% and 80%. All the samples contained cells of all 
epithelial layers (including basal and parabasal layers) because of specialized designed rigid 
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hairs of CDx brush. This is an advantage, which can resolve the problem of false negative 
and inadequate results and help to improve sensitivity. It is the first attempt to apply Liquid 
Based Cytology (LBC) using a specialized oral cytology instrument (OralCDx® Brush), 
hence other LBC studies in oral cavity have used cervical or dermatologic tools for sample 
collection(Hayama et al. 2005; Navone et al. 2007). 
 
 
Fig. 1. Patient NO.25. A) malignant changes (posterior portions) in a severely dysplastic 
leukoplakia(anterior portions) on maxillary gingiva. B)LBC prepared cytologic slides 
revealed dysplasia in leukoplakic area ,note to different nucleus size and high protein 
synthesis activity (100X magnification – Papanicolaou staining) 
False negative ratio (11%=2/18) was slightly higher than other studies (3.5%, 1.9%, 5%) 
(Christian 2002;Potter, Summerlin, and Campbell 2003; Scheifele et al 2004; Navone et al 
2004). Because of small sample size, especially in premalignant lesions, it is not possible to 
www.intechopen.com
 
Oral Cancer 
 
198 
compare researches. Svirsky reported 4 false negatives but three out of four false negative 
results seemed to originate from incompatible site and time of both biopsy techniques; 
indeed only 1 “ false negative" was reported which could be the result of the technique per 
se. Other negative results seemed to originate from (Svirsky et al. 2002). In our study, 
performing brush biopsy simultaneously on the exact biopsy site could compensate this 
shortcoming. 
Two clinically diagnosed malignancies (OSCCs)-proved to be granular cell tumors of 
tongue- had negative brush results. This suggests more specificity for brush compared to 
clinical diagnosis. SN 88.8% was almost similar to some results of oral exfoliative cytology 
researches (86.5%, 71.4% and 92.3%) (Scheifele et al. 2004; Navone et al. 2004; Poate et al. 
2004; Sciubba 1999) and in contrast to results of other study with extremely high SN (100%) 
(Sciubba 1999).100% PPV was higher than previous studies (38.3% 7.4%and 7.9%) 
(Bhoopathi, Kabani, and Mascarenhas 2009; Svirsky et al. 2002), which can be due to higher 
prevalence of dysplasia and malignancy in our sample group. 
LR+ and LR- are two tools that combine information about the SN and SP of a test and are 
not commonly reported in oral medicine’s literature. LR+ >10 and LR- <0.1 makes a test 
suitable for clinical use. They were infinity and 0.11 respectively that empress positive 
results may be always true .It seems that this finding is because of great prevalence of 
disease in study group and larger sample size can near this result to more realistic value. 
LR- =0.11 shows “moderate decrease in the likelihood of the disease”. 
There was a high diagnostic agreement between brush biopsy and histopathologic 
examination. In two dysplastic lesions the brush could not reveal atypical changes, so 
contingency coefficient was  92.3%. Kappa value was calculated to show diagnostic 
agreement. Based on literature review Kappa value has not been calculated for brush biopsy 
yet. Kappa  result (0.806) was greater than 0.7 and shows substantial agreement between 
brush biopsy and scalpel biopsy. 
Based on our study, high SN,SP, LR+ and Kappa value, showed that modified LBC is a 
suitable test for clinical use. Our modification can eliminate some of the disadvantages of 
conventional, brush and liquid –based cytology, previously attempted in oral cavity. This 
study has some great advantages:1)All subjects under went scalpel biopsy so we could 
compare our results with gold standard so the reported SN,SP,PPV and NPV are 
reliable.2)Both samples were obtained from the same site.3)The special oral brush was used 
to collect cells for LBC. It seems that our study combines the benefits of brush biopsy and 
LBC in early detection of oral premalignant and malignant changes.  
2.3 Vital tissue staining  
2.3.1 Vital iodine stain 
Vital iodine stain (3% lugol solution) has been used to determine the best site for biopsy in 
endoscopy of alimentary tract and cervix.(Navone 2009).This technique works on binding of 
iodine to glycogen granules in the cytoplasm, resulting in a black brown tissue color(Maeda 
et al. 2010; Maeda et al. 2009) . In a study of 54 patients with oral cancer or OPL, this dye 
was used to determine surgical margins. The results showed a significantly low(<2%) 
recurrence rate(Navone 2009). 
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Patient 
number 
Age(Yrs.) Sex* 
Clin 
Dia. † 
Brush 
Results 
Histo 
Dia. ‡ 
(P.D.M.H) 
§ 
1 65 M SCC¶ Pos SCC level 5 
2 48 M LEUK** Pos LEUK level 3 
3 71 M SCC Pos SCC level 5 
4 67 F SCC Pos SCC level 5 
5 74 M LEUK Pos LEUK level 1 
6 40 M LEUK Neg LEUK level 2 
7 79 F LEUK Neg OLP†† level 1 
8 70 F SCC Pos SCC level 5 
9 49 F SCC Neg GCT Normal 
10 74 F SCC Pos SCC level 5 
11 73 F Ver.car†† Pos Ver.car level 5 
12 55 F OLP‡‡ Pos OLP level 2 
13 70 M OLP Neg OLP Normal 
14 47 F SCC Pos SCC level 5 
15 36 M OLP Neg OLP Normal 
16 36 M OLP Neg OLP Normal 
17 39 M SCC Pos SCC level 5 
18 69 M SCC Pos SCC level 5 
19 35 F SCC Pos SCC level 5 
20 64 M SCC Pos SCC level 5 
21 35 M OLP Neg OLP Normal 
22 52 M OLP Neg OLP Normal 
23 42 F SCC Neg GCT Normal 
24 70 F LEUK Neg LEUK Normal 
25(Lesion1) 22 F LEUK Pos LEUK level 3 
25(Lesion2) 22 F SCC Pos SCC level 5 
Abbreviations: *sex is defined as Male(M) and Female(F),†Clinical diagnosis,‡ histopathological 
diagnosis, § presence of dysplasia/malignancy in histopathology, ¶ squamous cell carcinoma, 
**leukoplakia, †† verrucous carcinoma,,‡‡ oral lichen planus or lichenoid reaction .Brush biopsy results 
are defined as Positive (Pos),Negative(Neg ),and in adequate results(IAR) 
Table 4. Demographic data in addition to clinical ,modified(Liquid-Based) brush biopsy and 
histopathological diagnosis. 
2.3.2 Toluidine blue staining  
Toluidine blue (TB) is a metachromatic dye that binds to nucleic acids(DNA or RNA) and 
can help to better visualization of high risk areas-with rapid cell proliferation of oral SCC or 
OPL.This will guid the clinician to : 
- Detect carcinoma in situ and early invasive OSCC 
- Delination of surgical fields for biopsy sites 
- Detection of second primary cancers or satellite tumors 
- Recognition of post-treatment recurrence(Rosenberg and Cretin 1989) 
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There have been some studies about diagnostic accuracy of TB staining (Epstein et al. 2008; 
Epstein and G¸neri 2009; Lingen et al. 2008; Patton, Epstein, and Kerr 2008; Rhodus 
2009).These studies have addressed some limitations. Ligen et al reviewed these studies and 
concluded that absence of randomized clinical trials and histological diagnosis as gold 
standard and variability of methods of applications are the major factors in exact diagnostic 
value of TB. (Lingen et al. 2008)In other reported studies, SN is high but SP is low due to dye 
absorption by inflammatory lesions. It is a cheap, easy and none-invasive technique. 
(Epstein and G¸neri 2009; Epstein et al. 2007; Rhodus 2009). SN and SP are calculated at 38-
100% and 9-100 %,respectively .(Awan, Morgan, and Warnakulasuriya 2011; Epstein and 
G¸neri 2009; Epstein et al. 1997; Martin, Kerawala, and Reed 1998; Warnakulasuriya and 
Johnson 1996) 
It seems that SN in detecting dysplasia is still low. A high false positive result is a great 
limitation of clinical implication as a screening method. Sometimes subjective interpretation of 
the mucosal staining (dark royal blue compared to pale blue) cause differences in 
results(Lingen et al. 2008).A comprehensive review on clinical effectiveness of TB showed that 
TB is not a cost-effective method of picking up OSCC in primary care setting (Gray et al. 2000). 
ViziLite plus is a system which uses TB in combination with ViziLite pens- a disposable 
chemiluminescent light device- to enhance the malignant changes of oral mucosa (see light-
based detection systems) 
2.3.3 Other staining methods  
Methylene blue has been used for detection of oral cancer and OPL.SN, SP, PPV and NPV 
has been reported 90%, 69%, 74% and 87% respectively (Chen, Lin, Fong, et al. 2007; Chen, 
Lin, Wu, et al. 2007). 
Rose bengal RB has been used to detect non-healthy epithelial mucosa such as ocular 
epithelium specially neoplasms(Kim 2000; Khan-Lim and Berry 2004; Wilson 2nd 1976; 
Singh et al. 2004) . One study was conducted in 132 cases of oral OPLs and oral SCC with a 
refined 4-grades shade guide. The results showed SN, SP, PPV and NPV to be 93.9%, 73.7%, 
55.4% and 97.2% respectively. Six lesions with normal appearance in clinical examination 
were disclosed by RB staining. The authors concluded that RB staining can be used as a 
valuable diagnostic procedure in hospital-based population (with a high prevalence of 
malignancy dysplasia). Further research is necessary to reveal its benefits as a screening test 
(Du et al. 2007). 
2.4 Light-based detection systems  
2.4.1 Chemluminescence (reflective tissue fluorescence)  
In this technique the mouth is rinsed with 1% acetic acis wash, which helps to remove debris 
and increase the visibility of epithelial cell nuclei as a result of mild cellular dehydration. 
The blue white illumination will be reflected by abnormal tissue, making occult lesion 
distinguishable from normal mucosa (Lingen et al. 2008). The normal mucosa appears blue 
whereas abnormal mucosal lesions reflect the light and appear more aceto-white with 
brighter, sharper and more distinct margins (Epstein et al. 2006; Farah and McCullough 
2007; Kerr, Sirois, and Epstein 2006; Ram and Siar 2005). 
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In a clinical survey of 150 patients visiLite system was used to examine oral lesions. Since all 
lesions were not biopsied and compared with gold standard, diagnostic accuracy was not 
achieved (Huber, Bsoul, and Terezhalmy 2004).One case with normal clinical appearance 
was detected by ViziLite. All cases of leukoedema were aceto-white. These finding suggest 
that despite high SN of ViziLite, SP is still low. Several studies about viziLite examination 
for case-finding or screening of oral cancer (Farah and McCullough 2007; Huber, Bsoul, and 
Terezhalmy 2004; Oh and Laskin 2007) but the majority of them lack histopathologic 
correlation, which questions the diagnostic value. Most researchers found that this device 
has little benefit in discriminating Occult lesions. In addition distracting highlights 
produced by ViziLite system may make oral examination more difficult than with normal 
operating light (Oh and Laskin 2007). If well controlled clinical trials can show it’s benefit in 
differentiating lesions, from normal appearing mucosa, this technology can be used as a true 
screening tool (Lingen et al. 2008). 
Some studies(Bhalang et al. 2008; Oh and Laskin 2007) showed benefit with the use of acetic 
acid 1% or vinegar (5% acetic acid) prerinse for better visualization of oral mucosa, so acetic 
acid can be used without the accompanying light system. 
2.4.2 Tissue fluorescence imaging  
In this technique an intense blue excitation light (400-460 nm) is illuminated to oral mucosa 
and the abnormal tissue emits fluorescence due to altered structure and metabolism of 
epithelium and subepithelial stroma. Normal mucosa emits a pale green autofluorescence 
while abnormal tissue appears darker in comparison to surrounding healthy tissue. 
Microlux, orascoptic and veloscope are examples of this technique. Case series have found 
high sensitivity (98-100%) and specificity (3-100%) of veloscope in identifying areas of 
dysplasia and cancers that extended beyond the clinically evident tumors(Abdo et al. 2007; 
De Veld et al. 2005; Lingen et al. 2008; Onizawa et al. 1999; Patton, Epstein, and Kerr 
2008).To date there are no puplished studies about using veloscope as a diagnostic adjunct 
in screening low risk population or in patients examined by primary health care providers 
(Lingen et al. 2008). 
2.4.3 Tissue fluorescence spectroscopy  
This technique consists of a small optical fiber that produces various excitation wave lengths 
and a spectrograph which receives and records on a computer and analyzes via a dedicated 
software, the spectra of reflected fluorescence from the tissue (De Veld et al. 2005; Inaguma 
and Hashimoto 1999; Lingen et al. 2008; Patton, Epstein, and Kerr 2008). This technique is 
very accurate in distinguishing normal mucosa from different lesions, but due to small size 
of optical fiber it is not practical to scan large areas of oral mucosa. Also it can not 
distinguish benign lesions from malignancy (De Veld et al. 2005; Inaguma and Hashimoto 
1999; Lingen et al. 2008; Patton, Epstein, and Kerr 2008). 
2.4.4 Other light-based techniques  
Contact endoscopy and endoscopic high frequency ultra sound are promising new imaging 
systems which have been used in nasopharyngeal lesions. These techniques has been used 
in oral cavity and a SN=91.3% and SP=100% have been reported (Mallia et al. 2008). Narrow 
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band imaging is a novel technique which uses narrow-band spectrum optical filters to 
enhance the visualization of mucosal and sub-mucosal microvascular patterns. (Piazza et al. 
2010) SN, SP, PPV and NPV for this technique in combination with a high definition 
television have been reported as 96%, 100%, 100% and 93% respectively (Piazza et al. 
2010).Further research is necessary to better understand the diagnostic value of these new 
technologies (Andrea et al. 1997; Andrea, Dias, and Santos 1995; Speight et al. 1995). 
2.5 Cellular and molecular techniques  
There are many diagnostic aids which can detect premalignant and malignant changes in 
cellular and molecular level at early stages. Examples are cytomorphometric and 
histomorphometric analysis, molecular analysis and genetic alteration assessment. These 
methods employ immunohistochemistry, histochemistry and immunologic techniques in 
detection of early changes. Yet these techniques are used for research purposes and are not 
clinically applicable. (Bourhis et al. 1996 ;Remmerbach et al. 2001; Maraki, Becker, and 
Boecking 2004; Maraki, Hengge, et al. 2006; Maraki, Yalcinkaya, et al. 2006; Yamazaki et al. 
2008 ; Nagamani et al. 2010;Mohtasham et al. 2010; OHTA et al. 2010;Böcking et al. 2011).In 
addition these methods are expensive and are not widely accessible and only expert 
clinicians can use them for early diagnosis. More studies must be conducted to evaluate 
these techniques as screening methods of oral cancer.  
3. Conclusion 
There are many diagnostic aids for early detection of oral cancer. Yet the gold standard of 
oral cancer diagnosis is surgical biopsy, which can be performed by a trained 
dentist/physician. Diagnostic aids can be used in different situations specially when a 
surgical biopsy is not indicated and can help the clinician to: 
1. Choose the best site for biopsy 
2. Follow up a patient with a premalignant lesion 
3. Screen for oral cancer in high risk patients or high risk sites of oral cavity (e.g. ventral 
tongue, floor of the mouth etc.)  
4. Make a preliminary diagnosis when there is a systemic contraindication for surgical 
biopsy 
5. Differentiation of pseudoepitheliomatous hyperplasia from a real malignancy. 
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